132 related articles for article (PubMed ID: 21062669)
1. Estrogens and men with schizophrenia: is there a case for adjunctive therapy?
Kulkarni J; de Castella A; Headey B; Marston N; Sinclair K; Lee S; Gurvich C; Fitzgerald PB; Burger H
Schizophr Res; 2011 Feb; 125(2-3):278-83. PubMed ID: 21062669
[TBL] [Abstract][Full Text] [Related]
2. Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study.
Bergemann N; Parzer P; Kaiser D; Maier-Braunleder S; Mundt C; Klier C
Psychoneuroendocrinology; 2008 May; 33(4):507-16. PubMed ID: 18343039
[TBL] [Abstract][Full Text] [Related]
3. Estrogen in severe mental illness: a potential new treatment approach.
Kulkarni J; de Castella A; Fitzgerald PB; Gurvich CT; Bailey M; Bartholomeusz C; Burger H
Arch Gen Psychiatry; 2008 Aug; 65(8):955-60. PubMed ID: 18678800
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.
Bergemann N; Mundt C; Parzer P; Jannakos I; Nagl I; Salbach B; Klinga K; Runnebaum B; Resch F
Schizophr Res; 2005 Mar; 73(2-3):357-66. PubMed ID: 15653282
[TBL] [Abstract][Full Text] [Related]
5. Estrogen and comprehension of metaphoric speech in women suffering from schizophrenia: results of a double-blind, placebo-controlled trial.
Bergemann N; Parzer P; Jaggy S; Auler B; Mundt C; Maier-Braunleder S
Schizophr Bull; 2008 Nov; 34(6):1172-81. PubMed ID: 18156639
[TBL] [Abstract][Full Text] [Related]
6. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
7. Hormone modulation: a novel therapeutic approach for women with severe mental illness.
Kulkarni J; Gurvich C; Gilbert H; Mehmedbegovic F; Mu L; Marston N; Gavrilidis E; de Castella A
Aust N Z J Psychiatry; 2008 Jan; 42(1):83-8. PubMed ID: 18058448
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
[TBL] [Abstract][Full Text] [Related]
9. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
Ritsner M; Gibel A; Ram E; Maayan R; Weizman A
Eur Neuropsychopharmacol; 2006 Feb; 16(2):137-46. PubMed ID: 16139994
[TBL] [Abstract][Full Text] [Related]
10. Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial.
Ko YH; Lew YM; Jung SW; Joe SH; Lee CH; Jung HG; Lee MS
J Clin Psychopharmacol; 2008 Aug; 28(4):375-83. PubMed ID: 18626263
[TBL] [Abstract][Full Text] [Related]
11. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
[TBL] [Abstract][Full Text] [Related]
12. Combination of estrogen and antipsychotics in the treatment of women with chronic schizophrenia: a double-blind, randomized, placebo-controlled clinical trial.
Ghafari E; Fararouie M; Shirazi HG; Farhangfar A; Ghaderi F; Mohammadi A
Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):172-6. PubMed ID: 23302446
[TBL] [Abstract][Full Text] [Related]
13. Sex hormones in psychotic men.
Huber TJ; Tettenborn C; Leifke E; Emrich HM
Psychoneuroendocrinology; 2005 Jan; 30(1):111-4. PubMed ID: 15358449
[TBL] [Abstract][Full Text] [Related]
14. Serum testosterone levels are related to cognitive function in men with schizophrenia.
Moore L; Kyaw M; Vercammen A; Lenroot R; Kulkarni J; Curtis J; O'Donnell M; Carr VJ; Shannon Weickert C; Weickert TW
Psychoneuroendocrinology; 2013 Sep; 38(9):1717-28. PubMed ID: 23490072
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial of adjunctive oestrogen treatment in women with schizophrenia.
Kulkarni J; Riedel A; de Castella AR; Fitzgerald PB; Rolfe TJ; Taffe J; Burger H
Arch Womens Ment Health; 2002 Nov; 5(3):99-104. PubMed ID: 12510212
[TBL] [Abstract][Full Text] [Related]
16. Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus.
Dickerson FB; Stallings CR; Boronow JJ; Origoni AE; Sullens A; Yolken RH
Schizophr Res; 2009 Feb; 107(2-3):147-9. PubMed ID: 19008077
[TBL] [Abstract][Full Text] [Related]
17. Estrogen - a potential treatment for schizophrenia.
Kulkarni J; Riedel A; de Castella AR; Fitzgerald PB; Rolfe TJ; Taffe J; Burger H
Schizophr Res; 2001 Mar; 48(1):137-44. PubMed ID: 11278160
[TBL] [Abstract][Full Text] [Related]
18. Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial.
Nachshoni T; Ebert T; Abramovitch Y; Assael-Amir M; Kotler M; Maayan R; Weizman A; Strous RD
Schizophr Res; 2005 Nov; 79(2-3):251-6. PubMed ID: 16126372
[TBL] [Abstract][Full Text] [Related]
19. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
20. Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.
Hosseini SM; Farokhnia M; Rezaei F; Gougol A; Yekehtaz H; Iranpour N; Salehi B; Tabrizi M; Tajdini M; Ghaleiha A; Akhondzadeh S
Eur Neuropsychopharmacol; 2014 Jun; 24(6):846-55. PubMed ID: 24636461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
